2021 | | Adamantiades-Behçet's disease (Behçet's disease) and COVID-19 | 이은소 |
2024 | | All-cause and cause-specific mortality in patients with Behçet disease versus the general population | 이은소 |
2021 | | Alteration of the fecal but not salivary microbiome in patients with behçet’s disease according to disease activity shift | 박선, 이은소 |
2022 | | Association of chronic spontaneous urticaria with the first exposure to general anaesthesia | 김진철, 이은소, 최지웅 |
2023 | | Basic Therapeutic Approach for Patients with Plaque Psoriasis: Korean Expert Consensus Using the Modified Delphi Method | 이은소 |
2023 | | Clinical Characteristics of Psoriasis for Initiation of Biologic Therapy: A Cluster Analysis | 박범희, 이은소 |
2021 | | Clinical Features and Treatment Considerations When Switching Biologics in Korean Patients with Severe Psoriasis: A Retrospective Single-Centered Study | 이은소 |
2021 | | Clinical outcomes in adult patients with plaque psoriasis treated with ustekinumab under real-world practice in Korea: A prospective, observational, multi-center, postmarketing surveillance study | 이은소 |
2022 | | Comparative Analysis of Single-Cell Transcriptome Data Reveals a Novel Role of Keratinocyte-Derived IL-23 in Psoriasis | 김유찬, 박영준, 이은소 |
2019 | | Comparative Study of Clinical Characteristics according to Therapeutic Efficacy and Drug Survival of Cyclosporine or Methotrexate in Psoriasis Vulgaris | 이은소 |
2020 | | Comparison of Cytokine Expression in Paediatric and Adult Psoriatic Skin | 이은소 |
2023 | | Comparison of Short- and Long-Term Efficacy between Interleukin-17A and Interleukin-23 Inhibitors among Patients with Moderate-to-Severe Plaque Psoriasis: A Single Center Experience | 이은소 |
2022 | | Correlation of HLA-Cw6 Positivity with Clinical Characteristics and Treatment Efficacy in Korean Patients with Psoriasis | 이은소 |
2020 | | Differential expression of novel genes and signalling pathways of senescent CD8+ T cell subsets in Behcet's disease | 김소민, 박선, 이은소, 정재연 |
2022 | | Efficacy and safety of guselkumab compared with placebo and adalimumab in Korean patients with moderate-to-severe psoriasis: post-hoc analysis from the phase III, double-blind, placebo- and active-comparator-controlled VOYAGE 1/2 trials | 이은소 |
2020 | | Histopathological Features of Riehl Melanosis | 김유찬, 손성향, 이은소 |
2020 | | Impact of alopecia areata on psychiatric disorders: A retrospective cohort study | 이은소, 최지웅 |
2023 | | Integrative metabolomics of plasma and PBMCs identifies distinctive metabolic signatures in Behçet’s disease | 박선, 이은소 |
2024 | | Keratinocyte-derived circulating microRNAs in extracellular vesicles: a novel biomarker of psoriasis severity and potential therapeutic target | 박영준, 이은소, 정재연 |
2023 | | Natural History of Nevus Depigmentosus: A Long-term Follow-up Study of 102 Cases | 강희영, 김유찬, 김진철, 이은소 |
2022 | | No Association Between First Exposure to General Anaesthesia and Atopic Dermatitis in the Paediatric Population | 이은소, 최지웅 |
2022 | | Principal Component Analysis to Differentiate Patients with Palmoplantar Pustulosis from Those with Palmoplantar Pustular Psoriasis | 권지은, 박범희, 이은소 |
2023 | | Progression of Pre-Existing Vitiligo during Secukinumab Treatment for Psoriasis | 김진철, 이은소 |
2023 | | Real-World Outcomes of Adalimumab Treatment for Moderate and Severe Psoriasis in Korean Patients (RAPSODI Study) | 이은소 |
2020 | | Response to 'The incidence and survival of melanoma and nonmelanoma skin cancer in patients with vitiligo: a nationwide population-based matched cohort study in Korea' | 이은소, 최지웅 |
2020 | | Secukinumab Response in Korean Patients with Moderate to Severe Plaque-Type Psoriasis Irrespective of Previous Biologic Use: 1-Year Experience at a Single Center | 이은소 |
2019 | | The role of CCR1 and therapeutic effects of anti-CCL3 antibody in herpes simplex virus-induced Behcet's disease mouse model | 손성향, 이은소 |
2022 | | Unusual Case of Scalp Sarcoidosis with Alopecia: An Only Manifestation of Cutaneous Sarcoidosis without Systemic Involvement | 김진철, 이은소 |